Q4 2024 Management View CEO Noel Wallace highlighted net sales of $20 billion in 2024, achieving this milestone one year ...
Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.
Strong earnings, soaring organic sales, and record-breaking margins--Colgate is winning, but currency headwinds loom.
Buying Colgate-Palmolive Company shares after their 20% drop may not be a good idea for dividend or total return investors.
Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Colgate-Palmolive (CL – Research Report) ...
Morgan Stanley analyst Dara Mohsenian maintained a Buy rating on Colgate-Palmolive (CL – Research Report) today and set a price target of ...
Colgate Palmolive (India) reported a third-quarter profit that came in below market estimates on Tuesday, hurt by dwindling demand from urban consumers and higher expenses.
Ltd has reported a steady yet somewhat subdued financial performance for the third quarter and nine months ending 31 December 2024. In a world where Pepsodent, Sensodyne, and a slew of herbal ...